Oral drug dosage form comprising drug in the form of nanoparticles
US10973767B2 · kind B2 · utility
17Cited by
40References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 28, 2019 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Feb 28, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/192
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a stable solid pharmaceutical dosage form for oral administration. The dosage form includes a substrate that forms at least one compartment and a drug content loaded into the compartment. The dosage form is so designed that the active pharmaceutical ingredient of the drug content is released in a controlled manner.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.